That’s a wrap for ASCO 2024! We want to express our sincere gratitude to the numerous visitors who graced the Caris Life Sciences booth with their presence. It was a pleasure engaging with each of you to explore avenues for advancing precision medicine. Caris remains steadfast in its dedication to improving as many lives as possible. Discover more about our mission: https://lnkd.in/gX69hvc5 #ASCO24 #precisionmedicine
Caris Life Sciences’ Post
More Relevant Posts
-
Luigi Di Biase, MD, PhD, FACC, FHRS shares his top 3 late-breaking trials from #EHRA2024 Trials discussed include: - Novel Conformable "Single-Shot" PFA Catheter for Pulmonary Vein Isolation - ASTRO - AF: Ablation STrategies for Repeat Procedures in Patients with Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation - Style AF: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation
EHRA 24: 3 Trials that Will Change My Practice With Dr Luigi Di Biase
https://www.youtube.com/
-
Driven Regulatory Affairs professional with over 25 years experience in the Medical Device industry looking for a remote position
Check out these presentations by Matthew Mace from Acorai to learn about the upcoming alternatives in managing Heart Failure.
Exciting news! Our chief scientific officer, Matthew Mace, will present twice today at the Frankfurt CSI congress First up, catch him at the start-up competition in the Pink room at 16:15 CEST. Matthew will be sharing the latest data from the world of Acorai - you won't want to miss it! Immediately following, join Matthew and some esteemed colleagues in the Yellow Room at 17:30 for a session on other device-based heart failure therapies. Make sure to mark your calendars and attend these presentations. Matthew will be in Frankfurt until the end of the congress on Saturday. See you there! #CSIcongress #Acorai #HeartFailureTherapies #FrankfurtPresentation
-
-
Want to dive deeper into the ThrombUS Horizon EU Project we're involved in? Check out the video! And to stay always updated, be sure to subscribe to ThrombUS Newsletter: https://lnkd.in/dQA4UqXy #HorizonEurope #earlydetection #DVT
Introducing ThrombUS Horizon Europe Project
https://www.youtube.com/
-
🎥 #SCAI2024 Program Chair J. Dawn Abbott, MD, FSCAI, highlights the top moments from this year’s conference, while #SCAI2025 Program Chair Binita Shah, MD, FSCAI, shares exciting reasons to attend next year! Watch the interview and share your favorite moments from this year and your hopes for 2025 in the comments below! ➡️ https://lnkd.in/guSXGhSt #InterventionalCardiology
SCAI 2024 Highlights from Program Chairs Dr. J. Dawn Abbott and Dr. Binita Shah
https://www.youtube.com/
-
Chief Commercial Officer | Precision Medicine Innovative Servant Leader | Commercial Excellence | Oncology | NGS | Molecular Dx | Genetic Testing | Anatomic Pathology | Companion Dx | Health Equity
The transformation of healthcare and the drive to enhance patient care can only be achieved through strong partnerships. The shared mission of Velatura Public Benefit Corporation & Spesana is changing the continuum of care for clinicians and patients. Improved prior authorization means faster time to diagnosis and faster time to treatment. #partnerships #precisionmedicine #priorauthorization #healthcare #transformation #hie #interoperability #patientcare #moleculardiagnostics
Last month, Velatura and Spesana announced a pilot project that promises to propel the advancement of precision medicine and transform the prior authorization process for oncologists and specialty providers. Learn more about the impact here. ⬇
-
Here's Dr. Philip Judge's review of Dr. Leon Warne's insightful lecture on 'Pain Management of Osteoarthritis' from the WSAVA World Congress 2024 in Suzhou, China! Watch the video for key insights and let us know your thoughts in the comments below! #WSAVA2024
-
Yesterday, we hosted an insightful webinar with Prof. Duncan McLaren! Prof. McLaren discussed the PACE B study, highlighting potential links between acute GU toxicity and late toxicity. Some data also suggest that the use of fiducial markers and a regular LINAC also might be associated with higher toxicity. A key question raised: What are the benefits of using a catheter in prostate SBRT? This will be investigated in the upcoming PRECISION trial, a phase 2 study launching soon in the EU and US. The team in Scotland is just weeks away from enrolling their first patient, with 100 patients being the initial goal for all starting centers. The conversation also revolved around how the urethra is becoming the “new kid on the block” in prostate SBRT. More professionals are recognizing the patient benefits of focusing on the urethra, which naturally integrates into the workflow when using a catheter that enables urethra outlining during SBRT. Interested in learning more? We’re considering a follow-up session later this fall. By then, several centers, including Edinburgh, will have started the three-fraction protocol. Thanks to Prof. McLaren and everyone who joined! #ProstateCancer #SBRT #Radiotheraphy #Raypilot
-
-
What is the PROphet® NSCLC test? Watch this explanation of the PROphet® NSCLC test to grasp the intricacies of our clinical research, validation process, and the profound significance of the test results. Our commitment to scientific excellence is evident throughout the entire process to ensure accuracy, reliability, and relevance to advancing patient-centric solutions. Order PROphet® NSCLC - because the right start matters most >> https://bit.ly/3BfaMuN
-
Mark your calendars! Our CEO, Or Retzkin will be presenting at Biomed Israel 2024 next Tuesday, May 21st, at 11:45 AM. Don't miss the opportunity to learn more about how EyeControl's latest innovations are making strides in preventing and managing in-hospital cognitive deterioration. See you there! #EyeControl #BiomedIsrael #BrainTech #PatientSafety #PatientOutcomes #Delirium #MedInnovation
-
-
#ASH23: Dr. Jens Hillengass presents the results of the phase II CARTITUDE-2 Trial, including updated efficacy and safety data with a median follow-up of ~29 months. https://lnkd.in/gtdRsFCT
-
